Promising Developments at Dyne Therapeutics: Analyst Recommends ‘Buy’ Based on DYNE-101 and ‘251 Program Progress
Analyst Andrew Fein from H.C. Wainwright maintained a Buy rating on Dyne Therapeutics (DYN – Research Report) and keeping the price ...
Seeking Alpha15h
UP Fintech: A Buy On Strong Trading Volume And Newly Funded Account Growth
A Buy rating for TIGR is maintained, as the stock is attractively valued based on the comparison ... The company's revenue ...
Nifty below 23,600 as stocks sell off on earnings, valuation overhang: Key factors
Valuation concerns and earnings downgrades have continued to weigh on investor sentiment on November 13, with markets further ...
Buy Rating Affirmed for Beam Therapeutics Due to Promising BEAM-101 Developments in Sickle Cell Disease Treatment
William Blair analyst Sami Corwin has maintained their bullish stance on BEAM stock, giving a Buy rating today. Sami Corwin’s rating is ...
Stocks sell off on earnings and valuation overhang as Nifty tests 23,600: Key factors
Valuation concerns and earnings downgrades have continued to weigh on investor sentiment on November 13, with markets further ...
Press Trust of India on MSN8d
Sensex, Nifty climb in early trade on buying in IT stocks
BSE Sensex climbs 338.1 points to 79,814.73 in early trade; NSE Nifty jumps 101.5 points to 24,314.80 The Tribune ... The ...
bovnews7d
BofA Securities Issues Buy Rating for ONEOK Inc (OKE) Stock
On Wednesday, ONEOK Inc (OKE) stock saw a modest uptick, ending the day at $102.2 which represents a slight increase of $3.59 or 3.64% from the prior close of $98.61. The stock opened at $101.07 and ...
3 Focus Stocks: Alcon, Up Fintech, and Monolithic Power Systems
Watch Alcon (ALC) today. The stock should pop by at least 3.5% after markets react to its Q3 results. Alcon reported a non-GAAP EPS of $0.81. For the year, the firm is forecasting net sales to grow at ...
NBCC Share Price Target: Buy Multibagger PSU For Gain, Rs 800 Cr Orders Awarded In Nov
State-owned NBCC shares on Wednesday surged 4.64% to Rs 101.35 per share on Bombay Stock Exchange (BSE). NBCC (India) Ltd ...
Stock Traders Buy Large Volume of Call Options on Clover Health Investments (NASDAQ:CLOV)
Clover Health Investments, Corp. (NASDAQ:CLOV – Get Free Report) saw unusually large options trading on Thursday. Stock investors purchased 62,471 call options on the company. This represents an ...
Beam Therapeutics: Additional BEAM-101 And ESCAPE Tech Data At ASH 2024 Makes This A Watch
Stay updated on Beam Therapeutics Inc.'s latest advancements in Sickle Cell Disease and alpha-1 antitrypsin deficiency treatments. Click for my BEAM stock update.